• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Do the new ACG treatment guidelines have implications for Canada?

作者信息

Veldhuyzen van Zanten Sander, Krahn Thomas

机构信息

Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta T6G 2X8, Canada.

出版信息

J Can Assoc Gastroenterol. 2025 May 6;8(3):85-88. doi: 10.1093/jcag/gwaf008. eCollection 2025 Jun.

DOI:10.1093/jcag/gwaf008
PMID:40574829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12201999/
Abstract
摘要

相似文献

1
Do the new ACG treatment guidelines have implications for Canada?新的美国胃肠病学会（ACG）治疗指南对加拿大有影响吗？
J Can Assoc Gastroenterol. 2025 May 6;8(3):85-88. doi: 10.1093/jcag/gwaf008. eCollection 2025 Jun.
2
Evaluation of guidelines for diagnosis and treatment of Helicobacter pylori infection.幽门螺杆菌感染诊断与治疗指南评估
Helicobacter. 2023 Feb;28(1):e12937. doi: 10.1111/hel.12937. Epub 2022 Nov 21.
3
Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.用于根除幽门螺杆菌的序贯疗法与标准三联一线疗法对比
Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD009034. doi: 10.1002/14651858.CD009034.pub2.
4
Optimizing Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments.优化治疗：基于经验和药敏试验的治疗方法的最新综述。
Gut Liver. 2023 Sep 15;17(5):684-697. doi: 10.5009/gnl220429. Epub 2023 Feb 27.
5
Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.根除幽门螺杆菌的药物治疗方案：系统评价与网状Meta分析概述
BMC Gastroenterol. 2016 Jul 26;16(1):80. doi: 10.1186/s12876-016-0491-7.
6
Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?系统评价：益生菌对控制幽门螺杆菌在胃内的定植是否有用？
Aliment Pharmacol Ther. 2006 Apr 15;23(8):1077-86. doi: 10.1111/j.1365-2036.2006.02868.x.
7
The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria.抗生素治疗对感染幽门螺杆菌且患有慢性荨麻疹患者的影响。
J Am Acad Dermatol. 2003 Nov;49(5):861-4. doi: 10.1016/s0190-9622(03)00846-6.
8
Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta-analysis.幽门螺杆菌感染患者强化教育的效果：系统评价和荟萃分析。
Helicobacter. 2022 Apr;27(2):e12880. doi: 10.1111/hel.12880. Epub 2022 Feb 12.
9
Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection.牙周治疗作为胃幽门螺杆菌感染的辅助治疗
Cochrane Database Syst Rev. 2016 Feb 7;2(2):CD009477. doi: 10.1002/14651858.CD009477.pub2.
10
The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis.10 天铋剂四联疗法根除幽门螺杆菌的治愈率与 14 天疗法相当：系统评价和荟萃分析。
Clin Exp Med. 2023 Aug;23(4):1033-1043. doi: 10.1007/s10238-022-00953-7. Epub 2022 Dec 20.

本文引用的文献

1
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南：幽门螺杆菌感染的治疗
Am J Gastroenterol. 2024 Sep 1;119(9):1730-1753. doi: 10.14309/ajg.0000000000002968. Epub 2024 Sep 4.
2
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for infection between 2013 and 2021: results from the European registry on management (Hp-EuReg).2013年至2021年间含铋四联疗法治疗幽门螺杆菌感染的使用情况、有效性及安全性的演变：欧洲幽门螺杆菌管理登记研究（Hp-EuReg）结果
Gut. 2024 Dec 10;74(1):15-25. doi: 10.1136/gutjnl-2024-332804.
3
Success of Guideline-based Treatment of Newly Diagnosed and Previously Treated Patients During 2007-2021 in Edmonton, Alberta.2007年至2021年期间，在艾伯塔省埃德蒙顿对新诊断和既往接受过治疗的患者进行基于指南治疗的成效。
J Can Assoc Gastroenterol. 2023 Dec 14;7(3):221-229. doi: 10.1093/jcag/gwad051. eCollection 2024 Jun.
4
Standard Bismuth Quadruple Therapy versus Concomitant Therapy for the First-Line Treatment of Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.标准铋剂四联疗法与联合疗法用于感染一线治疗的比较：一项随机对照试验的系统评价和荟萃分析
J Clin Med. 2023 May 3;12(9):3258. doi: 10.3390/jcm12093258.
5
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.Vonoprazan 三联和双联疗法治疗美国和欧洲的幽门螺杆菌感染：随机临床试验。
Gastroenterology. 2022 Sep;163(3):608-619. doi: 10.1053/j.gastro.2022.05.055. Epub 2022 Jun 6.
6
Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis.2011 年至 2021 年美国幽门螺杆菌抗生素耐药性：系统评价和荟萃分析。
Am J Gastroenterol. 2022 Aug 1;117(8):1221-1230. doi: 10.14309/ajg.0000000000001828. Epub 2022 May 5.
7
Pharmacodynamics and Pharmacokinetics of the Potassium-Competitive Acid Blocker Vonoprazan and the Proton Pump Inhibitor Lansoprazole in US Subjects.美国受试者中钾竞争性酸阻滞剂 vonoprazan 和质子泵抑制剂兰索拉唑的药效学和药代动力学。
Am J Gastroenterol. 2022 Jul 1;117(7):1158-1161. doi: 10.14309/ajg.0000000000001735. Epub 2022 Mar 16.
8
Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why.幽门螺杆菌的药敏试验现已广泛可用：何时、如何以及为何进行。
Am J Gastroenterol. 2022 Apr 1;117(4):524-528. doi: 10.14309/ajg.0000000000001659.
9
Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg).治疗幽门螺杆菌期间的不良事件概况：来自欧洲幽门螺杆菌管理登记处（Hp-EuReg）的 22000 例患者的真实世界经验。
Am J Gastroenterol. 2021 Jun 1;116(6):1220-1229. doi: 10.14309/ajg.0000000000001246.
10
Rifabutin for the Treatment of Infection: A Review.利福布汀用于感染治疗的综述
Pathogens. 2020 Dec 28;10(1):15. doi: 10.3390/pathogens10010015.